Institutional Ownership Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM). We have compiled data on the 69 institutions that hold shares in the stock, with a total of 53.1 Million shares, which have been reported (via 13F filing form) to have a value of $218 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
70,093
shares
|
$288,082
0.0% of portfolio
|
Q3 2024
Added 309.23%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
68,600
shares
|
$281,946
0.0% of portfolio
|
Q3 2024
Added 85.41%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
59,046
shares
|
$242,679
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Nov 08, 2024 Q3 2024 |
58,411
shares
|
$240,069
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2024 Q3 2024 |
54,000
shares
|
$221,940
0.28% of portfolio
|
Q3 2024
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
53,674
shares
|
$220,600
0.01% of portfolio
|
Q3 2024
Added 74.78%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
49,524
shares
|
$203,543
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Advantage Alpha Capital Partners LP
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
48,169
shares
|
$197,974
0.06% of portfolio
|
Q3 2024
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
39,034
shares
|
$160,429
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
38,859
shares
|
$159,710
0.0% of portfolio
|
Q3 2024
Added 1428.08%
|
|
|
Superstring Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
33,824
shares
|
$139,016
0.15% of portfolio
|
Q3 2024
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
27,740
shares
|
$114,011
0.0% of portfolio
|
Q3 2024
Added 236.94%
|
|
|
Winton Group LTD
London, X0 |
Nov 12, 2024 Q3 2024 |
27,551
shares
|
$113,234
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
23,514
shares
|
$96,642
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
21,417
shares
|
$88,023
0.0% of portfolio
|
Q3 2024
Added 1212.32%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
18,280
shares
|
$75,130
0.0% of portfolio
|
Q3 2024
Added 45.54%
|
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Nov 13, 2024 Q3 2024 |
17,769
shares
|
$73,030
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
17,369
shares
|
$71,386
0.0% of portfolio
|
Q3 2024
Added 87.83%
|
|
|
Chicago Partners Investment Group LLC
|
Oct 28, 2024 Q3 2024 |
16,966
shares
|
$69,730
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
16,247
shares
|
$66,775
0.0% of portfolio
|
Q3 2024
Added 632.51%
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Nov 14, 2024 Q3 2024 |
16,064
shares
|
$66,023
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
13,885
shares
|
$57,067
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
13,248
shares
|
$54,449
0.0% of portfolio
|
Q3 2024
Added 320.7%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
12,776
shares
|
$52,509
0.0% of portfolio
|
Q3 2024
Added 311.6%
|
|
|
Valence8 Us LP
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
12,045
shares
|
$49,504
0.03% of portfolio
|
Q3 2024
New holding
|